Sagent Pharmaceuticals, Inc. Announces FDA Approval of Labetalol Hydrochloride Injection, USP
2/9/2010
More...
|
Lupin Ltd. (LUPN.BO) Receives FDA Approval for Amlodipine/Benazepril Capsules
2/9/2010
More...
|
Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Disease
2/9/2010
More...
|
ChemGenex Pharmaceuticals Limited (CXS.AX): Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
2/9/2010
More...
|
Chelsea Therapeutics, Inc. (CHTP) Announces Advancements in Neurogenic Orthostatic Hypotension Registration Program
2/9/2010
More...
|
Nymox Pharmaceutical (NYMX) Provides Update on Pivotal Phase 3 Trials for BPH Drug
2/9/2010
More...
|
Dynavax Technologies Corporation (DVAX) Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)
2/9/2010
More...
|
Penwest Pharmaceutical (PPCO) Initiates Second Phase IIa Clinical Trial for A0001
2/9/2010
More...
|
XOMA (US) LLC (XOMA) Initiates Phase 2b Dose-Ranging Clinical Trial of XOMA 052 in Type 2 Diabetes Patients
2/9/2010
More...
|
Palatin Technologies (PTN) Announces Dosing of Subcutaneous Bremelanotide Trial in Men
2/9/2010
More...
|
Provectus Pharmaceuticals Inc.'s PV-10 and Radiotherapy Featured in Peer Reviewed Journal
2/9/2010
More...
|
ThromboGenics NV: Positive Microplasmin Phase II Data Published in Ophthalmology
2/9/2010
More...
|
Stem Cell Therapeutics (SSS.V) Announces the Third and Final Positive Review by the Data Safety and Monitoring Board for the Modified REGENESIS Phase IIb Stroke Trial
2/9/2010
More...
|
Lithera Successfully Completes Phase I Clinical Trial of LIPO-102
2/9/2010
More...
|
Cerus Corporation (CERS) Reports Positive Outcome of Phase 1 Clinical Trial of INTERCEPT Red Blood Cells
2/9/2010
More...
|
Neogenix Oncology, Inc.: Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Novel Monoclonal Antibody
2/9/2010
More...
|
Transgenomic, Inc. (TBIO) Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR
2/9/2010
More...
|
Takeda Global Research & Development Center, Inc. Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate)
2/9/2010
More...
|
Sanofi-Aventis (France) (SASY.PA) Successfully Completes Tender Offer for Chattem, Inc. (CHTT)
2/9/2010
More...
|
NUCRYST Pharmaceuticals Corp. (WEDX) Announces Completion of Amalgamation
2/9/2010
More...
|
Cerus Corporation (CERS) to Collaborate with French National Transfusion Service on INTERCEPT Red Blood Cell Development
2/9/2010
More...
|
Targeted Genetics Corporation (TGEN) Receives Milestone Payments From Genzyme Corporation (GENZ)
2/9/2010
More...
|
EnviroLogix and the Danforth Plant Science Center Partner to Improve Nutrition in Staple Crops
2/9/2010
More...
|
T-Ray Science Announces Collaboration With the University of Leeds and Engagement of Investor Relations Firm
2/9/2010
More...
|
Picis, Inc. Signs 83 Major Customer Contracts in '09 for its High Acuity Solutions
2/9/2010
More...
|
SOHM India Signs Strategic Alliance With Pharmaceutical Manufacturer in the Tax Exempt Area of Himachal Pradesh, India
2/9/2010
More...
|
Caleco Pharma Corp. Engages ICF Kursmakler AG as Designated Sponsor on Frankfurt Stock Exchange and BlueWater Advisory Group LLC as Investor Relations Consultant
2/9/2010
More...
|
NexBio, Inc. Granted United States Patent Covering DAS181 (Fludase(R) *) and its Use for Prevention and Treatment of Influenza and Parainfluenza
2/9/2010
More...
|
Bohai Pharmaceuticals Group, Inc. Announces Ticker Symbol Change to "BOPH" Effective Today
2/9/2010
More...
|
Chattem, Inc. (CHTT) Gives Notice of Fundamental Change Conversion Rights to Holders of Convertible Senior Notes
2/9/2010
More...
|
Aastrom Biosciences, Inc. (ASTM) Announces One-for-Eight Reverse Stock Split
2/9/2010
More...
|
Nabi Biopharmaceuticals (NABI) Announces Mailing of Definitive Proxy Statement
2/9/2010
More...
|
Tianyin Pharmaceutical Co, Inc. Expects to Benefit from the Recently Published Guide to Pricing Reform for Medicine and Medical Services
2/9/2010
More...
|
PolyMedix Inc. Announces Planned Milestones for 2010
2/9/2010
More...
|
Tekmira Pharmaceuticals Corporation Announces 2010 Milestones
2/9/2010
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Reports Full Year and Fourth Quarter 2009 Results
2/9/2010
More...
|
Centene Corporation Reports 2009 Fourth Quarter and Full Year Earnings
2/9/2010
More...
|
Clinical Data, Inc. Reports Third Quarter Fiscal 2010 Results
2/9/2010
More...
|
Compugen Ltd. (CGEN) Reports Fourth Quarter and Calendar 2009 Financial Results
2/9/2010
More...
|
Crucell N.V. (CRXL) Announces Record Revenues and Profits for Full Year 2009
2/9/2010
More...
|
Exactech, Inc. (EXAC) Schedules Fourth Quarter and Full Year 2009 Earnings Release and Conference Call
2/9/2010
More...
|
Heska Corporation (HSKA) Announces Fourth Quarter and Year-End 2009 Earnings Conference Call Webcast
2/9/2010
More...
|
ISTA Pharmaceuticals, Inc. (ISTA) Announces 2010 Financial Guidance
2/9/2010
More...
|
Karo Bio AB: Year-End Report January-December 2009
2/9/2010
More...
|
Lannett Company, Inc. (LCI) Reports Fiscal 2010 Second-Quarter Financial Results
2/9/2010
More...
|
Ligand Pharmaceuticals Inc. (LGND) Announces Fourth Quarter and Full Year 2009 Consolidated Financial Results
2/9/2010
More...
|
PPD, Inc. (PPDI) Reports Fourth Quarter and Full Year 2009 Financial Results
2/9/2010
More...
|
OSI Pharmaceuticals, Inc. (OSIP) to Announce Fourth Quarter and Year-End 2009 Financial Results on February 23, 2010
2/9/2010
More...
|
Pacific Biomarkers, Inc. Schedules Second Quarter Conference Call
2/9/2010
More...
|
Savient Pharmaceuticals, Inc. (SVNT) To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
2/9/2010
More...
|
SeraCare Life Sciences, Inc. (SRLS) Reports First Quarter Fiscal Year 2010 Results
2/9/2010
More...
|
SXC Health Solutions to Host Fiscal 2009 Fourth Quarter and Year End Results Conference Call
2/9/2010
More...
|
Tianyin Pharmaceutical Co, Inc. Announces Record Second Quarter 2010 Financial Results
2/9/2010
More...
|
YM BioSciences (YM.TO) Reports Second Quarter 2010 Operational and Financial Results
2/9/2010
More...
|
Xencor Appoints Edgardo Baracchini, Ph.D., to Chief Business Officer
2/9/2010
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs
2/9/2010
More...
|
Aton Pharma, Inc. Announces Michael H. Richardson to Head Orphan Drug Division
2/9/2010
More...
|
Dr. Hoon Han Elected Chairman of the Board of Stem Cell Therapy International Corp.
2/9/2010
More...
|
Capstone Therapeutics (CAPS) to Present at 3rd Annual European Life Science CEO Forum
2/9/2010
More...
|
Emergence of "Femtomedicine" - New Frontier of Biomed Sciences - Reported at First Global Congress on Nano Medicine
2/9/2010
More...
|
Cardiogenesis Corporation (CGCP) to Present at the 5th Annual Stem Cell Summit
2/9/2010
More...
|
Osteologix Inc. to Present at 12th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/9/2010
More...
|